Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High power and single mode quantum cascade lasers.
Bismuto A, Bidaux Y, Blaser S, Terazzi R, Gresch T, Rochat M, Muller A, Bonzon C, Faist J. Bismuto A, et al. Among authors: bonzon c. Opt Express. 2016 May 16;24(10):10694-9. doi: 10.1364/OE.24.010694. Opt Express. 2016. PMID: 27409890 Free article.
Lasing in strained germanium microbridges.
Armand Pilon FT, Lyasota A, Niquet YM, Reboud V, Calvo V, Pauc N, Widiez J, Bonzon C, Hartmann JM, Chelnokov A, Faist J, Sigg H. Armand Pilon FT, et al. Among authors: bonzon c. Nat Commun. 2019 Jun 20;10(1):2724. doi: 10.1038/s41467-019-10655-6. Nat Commun. 2019. PMID: 31222017 Free PMC article.
A B7-H3-targeted CD28 bispecific antibody enhances the activity of anti-PD1 and CD3 T-cell engager immunotherapies.
Moore GL, Zeng VG, Diaz JE, Bonzon C, Avery KN, Rashid R, Qi J, Nam DH, Jacinto J, Dragovich MA, Kim YK, Balcazar KP, Bakhit CG, Eivazi A, Nguyen H, Muchhal US, Szymkowski DE, Desjarlais JR, Hedvat M. Moore GL, et al. Among authors: bonzon c. Mol Cancer Ther. 2024 Sep 20. doi: 10.1158/1535-7163.MCT-24-0327. Online ahead of print. Mol Cancer Ther. 2024. PMID: 39301613
Translational PK/PD and the first-in-human dose selection of a PD1/IL15: an engineered recombinant targeted cytokine for cancer immunotherapy.
Yadav R, Schubbert S, Holder PG, Chiang EY, Kiabi N, Bogaert L, Leung I, Rashid R, Avery KN, Bonzon C, Desjarlais JR, Sanjabi S, Sharma A, Lepherd M, Shelton A, Chan P, Liu Y, Joslyn L, Hosseini I, Stefanich EG, Kamath AV, Bernett MJ, Shivva V. Yadav R, et al. Among authors: bonzon c. Front Pharmacol. 2024 Jun 3;15:1380000. doi: 10.3389/fphar.2024.1380000. eCollection 2024. Front Pharmacol. 2024. PMID: 38887559 Free PMC article.
16 results